title: Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function.
abstract: Germline mutations in two major susceptibility genes, BRCA1 and BRCA2, account for nearly 20% of familial breast cancers. A majority of the remaining genetic factors involved in heritable breast cancer susceptibility are, however, unknown. Recently, a new BRCA1-interacting protein, receptor associated protein 80 (RAP80), was identified. RAP80 plays an important role in BRCA1-mediated DNA damage responses (DDRs) by recruiting BRCA1 to DNA double-strand breaks (DSBs). A comprehensive screening of DNA from affected index cases of 112 BRCA1/BRCA2 mutation-negative Finnish breast cancer families revealed altogether 10 alterations in RAP80, one of which, c.241-243delGAA, resulted in a single glutamic acid deletion at residue 81 in a highly conserved region of ubiquitin interaction motif 1. The resultant delE81 protein product displayed significantly reduced ubiquitin binding and DSB localization. Expression of the RAP80 delE81 allele impaired both BRCA1 and ABRA1 DSB recruitment, thus compromising BRCA1-mediated DDR signaling. Compared with wild-type RAP80, expression of the delE81 allele was associated with a significant increase in cytogenetically detectable chromosomal aberrations, particularly chromatid breaks. Although evidently quite rare, these results suggest that critical constitutional mutations in RAP80 abrogate DDR function and may be involved in genetic predisposition to cancer.
authors.affiliation: Department of Clinical Genetics and Biocenter Oulu, Oulu University Hospital, University of Oulu, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Nikkilä
authors.forename: K A
authors.initials: KA
authors.lastname: Coleman
authors.forename: D
authors.initials: D
authors.lastname: Morrissey
authors.forename: K
authors.initials: K
authors.lastname: Pylkäs
authors.forename: H
authors.initials: H
authors.lastname: Erkko
authors.forename: T E
authors.initials: TE
authors.lastname: Messick
authors.forename: S-M
authors.initials: SM
authors.lastname: Karppinen
authors.forename: A
authors.initials: A
authors.lastname: Amelina
authors.forename: R
authors.initials: R
authors.lastname: Winqvist
authors.forename: R A
authors.initials: RA
authors.lastname: Greenberg
mesh_terms: D019313:BRCA1 Protein / Q000502:physiology; D001943:Breast Neoplasms / Q000235:genetics*; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology; D053903:DNA Breaks, Double-Stranded; D004249:DNA Damage; D004268:DNA-Binding Proteins; D005260:Female; D042822:Genomic Instability; D056488:Histone Chaperones; D006801:Humans; D009154:Mutation; D009687:Nuclear Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology; D017434:Protein Structure, Tertiary; D025801:Ubiquitin / Q000378:metabolism
chemical_list: C520310:ABRAXAS1 protein, human; D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; D056488:Histone Chaperones; D009687:Nuclear Proteins; C466234:UIMC1 protein, human; D025801:Ubiquitin